HOME >> MEDICINE >> NEWS
Other highlights in the April 21 JNCI

t density in healthy women has not been known. To investigate this, Jack Cuzick, Ph.D., of Cancer Research UK in London, and colleagues analyzed mammograms from 818 breast cancer-free women from the International Breast Cancer Intervention Study 1, a trial that tested tamoxifen's ability to prevent breast cancer in healthy women at high risk of the disease.

Treatment with tamoxifen was associated with reduced breast density, most of which occurred within the first 18 months of treatment. In women aged 45 years and younger, breast density was reduced by 13.4% on average compared with only 1.1% in women older than 55 years. The researchers hypothesize that premenopausal women experienced a larger reduction because premenopausal estrogen levels are higher and so the antiestrogenic effect of tamoxifen will be greater.

Contact: Press Office, Cancer Research UK, +44 (0) 207 061 8300, pressoffice@cancer.org.uk

Low Categories of Benign Breast Disease Still Increase Risk of Breast Cancer

There are several breast abnormalities that are not cancerous, but some of these benign conditions are associated with a greater risk of breast cancer than others. A new study has found that even women with low-category benign breast diseases are at an increased risk of breast cancer compared with women without the disease.

Jiping Wang, M.D., Ph.D., of the University of Pittsburgh, and colleagues looked at medical records for 11,307 women from the Breast Cancer Prevention Trial, 1376 of whom had the low-category benign breast disease. Women with the disease were 60% more likely than women without the disease to develop invasive breast cancer. Women with benign breast disease aged 50 years or older had a 95% increased risk of developing invasive breast cancer compared to women without benign breast disease.

Contact: Lori Garvey, National Surgical Breast and Bowel Project, (412)330-4621, <
'"/>

Contact: Sarah L. Zielinski
jncimedia@oupjournals.org
301-841-1287
Journal of the National Cancer Institute
20-Apr-2004


Page: 1 2 3 4

Related medicine news :

1. Other highlights in the March 16 JNCI
2. Other highlights in the March 2 JNCI
3. Other highlights in the February 2 JNCI
4. Other highlights in the January 19 JNCI
5. Other highlights in the December 15 JNCI
6. Other highlights in the December 1 JNCI
7. Other highlights in the September 15 JNCI
8. Other highlights in the April 7 JNCI
9. Other highlights in the January 7 issue of JNCI
10. Other highlights in the December 3 issue of JNCI
11. Other highlights in the November 19 issue of JNCI

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Other highlights the April JNCI

(Date:5/26/2015)... Corner, VA (PRWEB) May 26, 2015 ... critical technology and management consulting solutions to the federal ... Technology Strategy and Cloud Solutions. In this newly created ... strategic capabilities and growth in cloud computing, big data, ... join our expanding leadership team as we continue to ...
(Date:5/26/2015)... Norcross, GA (PRWEB) May 26, 2015 ... its line of fresh, all-natural dog foods are now ... Dog Market in Atlanta and The Good Old Dog ... Norcross, Georgia where they’ve recently opened a state-of-the-art, climate ... farmers and farmers’ markets and all of the food ...
(Date:5/26/2015)... New Brunswick (PRWEB) May 26, 2015 ... announce the successful upgrade of the DMi Partners ... This version was the first in Indosoft's contact center ... API improvements, added screen support for such trunk features ... screens, improved lead management, and included upgrades to ...
(Date:5/26/2015)... San Antonio, TX (PRWEB) May 26, 2015 ... announce the opening of its newest clinic on May 25, ... found at 1919 Rogers Road, Suite 102 in Westover Hills ... late as 7 P.M. , “We’re thrilled about opening ... to reach more of our neighbors in San Antonio and ...
(Date:5/26/2015)... 2015 ProTrailer Network is a new ... Pro X . This Effect includes 30 all ... styled text. , ProTrailer Network allows users to ... can easily complement any form of media project. FCPX ... can make professional looking openers. , ProTrailer Network includes ...
Breaking Medicine News(10 mins):Health News:Octo Consulting Group (Octo) Appoints Gaurav “GP” Pal as Vice President of Technology Strategy and Cloud Solutions 2Health News:Allprovide, the All-Natural Pet Food, Available At Georgia Retailers 2Health News:DMi Partners Upgrades to Indosoft Q-Suite 5.8 2Health News:DMi Partners Upgrades to Indosoft Q-Suite 5.8 3Health News:TexPTS Announces New Clinic in San Antonio 2Health News:Developers at Pixel Film Studios Release ProTrailer Network for Final Cut Pro X 2
(Date:5/26/2015)... -- BioSpecifics Technologies Corp. (NASDAQ: BSTC ), a biopharmaceutical ... XIAFLEX ® in the U.S. and XIAPEX ® ... Tom Wegman , will present a corporate overview ... The presentation will take place on Monday, June ... New York, NY . A live webcast of ...
(Date:5/26/2015)... May 26, 2015 ViiV Healthcare, ... (CHAI) announced today that Aurobindo Pharma has submitted an ... Tentative Approval, to the Food and Drug Administration (FDA), ... ANDA for a generic version of dolutegravir, less than ... sale in the United States . ...
(Date:5/26/2015)... Israel , May 26, 2015 /PRNewswire/ ... Dario™ Diabetes Management Solution, announced today that ... leading HMO, Maccabi Healthcare, it has ... as part of Maccabi,s advanced Telecare unit ... diabetes management solution that enables remote treatment ...
Breaking Medicine Technology:BioSpecifics Technologies Corp. to Present at the Jefferies 2015 Healthcare Conference 2ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 2ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 3ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 4ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 5ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 6ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 7LabStyle Innovations and Maccabi Healthcare Launch Dario Platform for Remote Treatment of Diabetes in Israel 2LabStyle Innovations and Maccabi Healthcare Launch Dario Platform for Remote Treatment of Diabetes in Israel 3LabStyle Innovations and Maccabi Healthcare Launch Dario Platform for Remote Treatment of Diabetes in Israel 4
Cached News: